Your One True Source of Alternative Data
Eagle Alpha is the leading alternative data aggregation platform and advisor.Setting the Industry Standard for the Application of Alternative Data
We facilitate the overall functioning of the global alternative data market via our platform and workflow tools. Since its inception, more than 1,000 data buyers have interacted with our platform. We help them understand a vast and growing marketplace of over 2,500 alternative data products. Leading funds, private equity firms, consultants, corporates, and vendors trust Eagle Alpha as their key alternative data solution provider.
Recent Alternative Data Content by Eagle Alpha
Alternative Data: The Source of ESG Truth
Our blog highlights the surging interest in ESG, with growing regulatory and investor demand for sustainable and socially responsible investment practices boosting ESG funds’ AUM.
Alternative Data: The Source of ESG Truth
A data-driven ESG approach can enable more informed engagement with companies. Alternative data can help plug gaps in regulatory reporting requirements
Alternative Data in Emerging Markets Asia
Our blog notes a surge in demand for alternative data from Emerging Markets Asia, especially China, with both international and local managers keen on regional insights.
Eurozone Inflation to Burn Hotter, but ECB Rates to Stay on Ice
Our blog discusses the rise in 2022 inflation forecasts across Europe due to supply chain issues and higher energy/food prices, impacting Europe Regional bond fund strategies.
Alternative Data Vendors Offer New Perspectives to Private Equity Firms
Eagle Alpha has been actively working with data-driven private equity firms that are keen to integrate alternative data into their established investment processes. This approach signifies a new frontier in investment strategy, where conventional methods are augmented by rich, diverse datasets.
Alternative Data for Healthcare
This white paper explores the impact of alternative data sources on the healthcare industry, emphasizing their role in enhancing investment decisions in healthcare startups, therapies, and market trends. It delves into patient-generated data, wearables, mobile health apps, social media discussions, and electronic health records (EHRs) as key non-traditional data sources. The report segments healthcare data into four primary categories: R&D and clinical trials, claims data, medical devices data, and other relevant datasets, underscoring the transformative role of AI in healthcare processes. The paper includes sections on investment trends in pharma and biomed, data availability and its applications, the evolution of the pharma industry through AI, real-world case studies demonstrating successful data utilization, and compliance considerations for investors. This summary offers a glimpse into the comprehensive insights provided in the full report by Eagle Alpha, which further includes additional case studies and details on alternative data providers not covered here. For more detailed information and access to a broad catalog of data products, the report encourages contacting Eagle Alpha directly.
Get a Demo
Request a demo of the vendor or buyer journey on our platform to learn how our services and solutions can help you unlock the potential of alternative data.